SEC Form 4 · accession 0001140361-15-036873
Medite Cancer Diagnostics, Inc. · MDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michaela Ott
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Oct 5, 2015
Accepted (ET)
Oct 5, 2015 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000075439
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per shareF1 | Oct 5, 2015 | P$0 | 156,250 | — | A | 7,500,000 | D | |
| Common Stock, par value $0.001 per shareF1 | Oct 5, 2015 | P$0 | 156,250 | — | A | 7,500,000 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance of shares due pursuant to a share exchange agreement.